Chris Jacobs sold BXP, Inc. (NYSE: BXP)
Chris Jacobs (R-NY), a U.S. Representative, has disclosed 1 trade in BXP, Inc. (BXP) since 2020, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Chris Jacobs sold $1,001 - $15,000 of BXP, Inc. (NYSE: BXP) on September 8, 2020. Since that trade, BXP is up +12.65% against the S&P 500 up +137.11%, an outperformance of -124.47%.
Data updated
Chris Jacobs's BXP trades vs the price
BXP is up +12.65% since Chris Jacobs sold on September 8, 2020, versus +137.11% for the S&P 500.
Performance since this trade
All Chris Jacobs BXP trades
Chris Jacobs & BXP trading FAQ
Is it legal for Chris Jacobs to trade BXP, Inc. (BXP) stock?
Yes. Members of Congress are allowed to trade individual stocks, including BXP, Inc. (BXP), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Chris Jacobs sell BXP?
Chris Jacobs disclosed a sale of $1,001 - $15,000 of BXP, Inc. (BXP) on September 8, 2020, according to public STOCK Act filings.
How has BXP performed since Chris Jacobs's trade?
Since Chris Jacobs sold BXP on September 8, 2020, the stock is up +12.65%, versus +137.11% for the S&P 500 over the same period, an outperformance of -124.47%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BXP trades?
Quantellect tracks every disclosed congressional trade in BXP, Inc. (BXP) on the BXP, Inc. congressional trading page, which aggregates filings across all members of Congress.
Chris Jacobs's BXP tradesAll congressional filings for BXP, Inc.Chris Jacobs's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.